Stock listing

Cellectis S.a.

Selected listing: ALCLS · EURONEXT · EUR · FR

Cellectis S.a. (Euronext:ALCLS), Health Technology. Latest release Oct 6, 2026: Monthly information on share capital and company voting rights.

ALCLS:EURONEXTEURFRUpdated October 2, 2026

Ticker: Euronext:ALCLS
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Euronext
Currency: EUR

About Cellectis S.a.

Cellectis S.A. is a public biotechnology company based in France, trading under the ticker ALCLS. The company focuses on developing innovative gene-editing technologies for therapeutic applications.

Latest news from Cellectis S.a.

Monthly information on share capital and company voting rights

October 6, 2026

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

September 14, 2026

Cellectis annonce sa transformation stratégique en société d'édition du génome in vivo

September 13, 2026

Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update

September 10, 2026

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

September 2, 2026

All Cellectis S.a. news →

Events

Replays

Cellectis Inc. (CLLS) Q1 2026 Earnings Call
Mon, May 11, 2026 · 12:00 AM ET
Watch
Cellectis Inc. (CLLS) Q4 2025 Earnings Call
Fri, Mar 20, 2026 · 08:00 AM ET
Watch
Cellectis Inc. (CLLS) Q2 2025 Earnings Call
Tue, Aug 05, 2025 · 08:00 AM ET
Watch

Research Cellectis S.a.

Cellectis S.a. company profile

View the public company page for Cellectis S.a. on 6ix.

Cellectis S.a. news

Read company news and market updates connected to Cellectis S.a..

Cellectis S.a. investor events

Find investor webinars, events, and replay context for Cellectis S.a..